Predictive validity and clinical utility of DSM-5 Somatic Symptom Disorder - Comparison with DSM-IV somatoform disorders and additional criteria for consideration

Journal of Psychosomatic Research

Volumn 73, Issue 5, 2012, Pages 345-350

  Voigt, Katharina ^a   Wollburg, Eileen ^b   Weinmann, Nina ^b   Herzog, Annabel ^a   Meyer, Björn ^c   Langs, Gernot ^b   Löwe, Bernd ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Schön Clinic Bad Bramstedt   (Germany)

^c GAIA AG   (Germany)

Author keywords

Classification of diseases; Diagnosis; Diagnostic and Statistical Manual of Mental Disorders; Somatoform disorder; Validation studies as topic

Indexed keywords

ADULT; ARTICLE; DSM-5; DSM-IV; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL CAPACITY; PREDICTIVE VALIDITY; PREDICTOR VARIABLE; PROSPECTIVE STUDY; SOMATIC SYMPTOM DISORDER; SOMATOFORM DISORDER;

ADULT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SOMATOFORM DISORDERS;

EID: 84867525449     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2012.08.020     Document Type: Article

References (37)

1. American Psychiatric Association Somatic Symptom Disorders 28-4-2012. Ref Type: Electronic Citation. http://www.dsm5.org/ProposedRevisions/Pages/proposedrevision.aspx?rid=368.
2. Creed F., Guthrie E., Fink P., Henningsen P., Rief W., Sharpe M., et al. Is there a better term than "medically unexplained symptoms"?. Journal of Psychosomatic Research 2010, 68:5-8.
3. Creed F. The relationship between somatic symptoms, health anxiety, and outcome in medical out-patients. The Psychiatric Clinics of North America 2011, 34:545-564.
4. American Psychiatric Association Justification of criteria-somatic symptoms Ref Type: Electronic Citation. http://www.dsm5.org/Documents/Somatic/Somatic%20Symptom%20Disorders%20description%20April%2018,%202011.pdf.
5. American Psychiatric Association Somatic Symptom Disorders Ref Type: Electronic Citation. http://www.dsm5.org/Documents/Somatic/Somatic%20Symptom%20Disorders%20description%20April%2018,%202011.pdf.
6. Lahmann C., Henningsen P., Dinkel A. Somatoforme und funktionelle St+Ârungen. Der Nervenarzt 2010, 81:1383-1396.
7. Martin A., Rief W. Relevance of cognitive and behavioral factors in medically unexplained syndromes and somatoform disorders. The Psychiatric Clinics of North America 2011, 34:565-578.
8. Martin A., Korn H.J., Cebulla M., Saly M., Fichter M.M., Hiller W. Causal attributions about bodily sensations in somatoform disorders [Kausalattributionen von körperlichen Beschwerden bei somatoformen Störungen]. Zeitschrift für Psychiatrie, Psychologie und Psychotherapie 2007, 55:31-41.
9. Rief W., Mewes R., Martin A., Glaesmer H., Braehler E. Are psychological features useful in classifying patients with somatic symptoms?. Psychosomatic Medicine 2010, 72:648-655.
10. Martin A. Does a somatic causal attribution style qualify for a diagnostic criterion in somatoform disorders?. Journal of Psychosomatic Research 2011, 70:239-240.
11. Rief W., Broadbent E. Explaining medically unexplained symptoms-models and mechanisms. Clinical Psychology Review 2007, 27:821-841.
12. Jensen J.C., Haahr J.P., Frost P., Hviid Andersen J. The significance of health anxiety and somatization in care-seeking for back and upper extremity pain. Family Practice 2012, 29:86-95.
13. Nakao M., Shinozaki Y., Ahern D.K., Barsky A.J. Anxiety as a predictor of improvements in somatic symptoms and health anxiety associated with cognitive-behavioral intervention in hypochondriasis. Psychotherapy and Psychosomatics 2011, 80:151-158.
14. Jackson J., Fiddler M., Kapur N., Wells A., Tomenson B., Creed F. Number of bodily symptoms predicts outcome more accurately than health anxiety in patients attending neurology, cardiology, and gastroenterology clinics. Journal of Psychosomatic Research 2006, 60:357-363.
15. Porcelli P., De Carne M., Todarello O. Prediction of treatment outcome of patients with functional gastrointestinal disorders by the diagnostic criteria for psychosomatic research. Psychotherapy and Psychosomatics 2004, 73:166-173.
16. Witthöft M., Rist F., Bailer J. Abnormalities in cognitive-emotional information processing in idiopathic environmental intolerance and somatoform disorders. Journal of Behavior Therapy and Experimental Psychiatry 2009, 40:70-84.
17. Duddu V., Isaac M.K., Chaturvedi S.K. Somatization, somatosensory amplification, attribution styles and illness behaviour: a review. International Review of Psychiatry 2006, 18:25-33.
18. Kroenke K., Sharpe M., Sykes R. Revising the classification of somatoform disorders: key questions and preliminary recommendations. Psychosomatics 2007, 48:277-285.
19. Üstün T.B., Jakob R., Celik C., Lewalle P., Kostanjsek N., Renahan M., et al. Production of ICD-11: the overall revision process 2007, www.who.int/classifications/icd/ICDRevision.pdf, World Health Organization, 16-7-2009. Ref Type: Electronic Citation.
20. Wittchen H.U., Zaudig M., Fydrich T. Strukturiertes Klinisches Interview für DSM-IV. Achse I: Psychische Störungen. SKID I 1997, Hogrefe, Göttingen.
21. Gräfe K., Zipfel S., Herzog W., Löwe B. Screening psychischer Störungen mit dem "Gesundheitsfragebogen für Patienten (PHQ-D)". Ergebnisse der deutschen Validierungsstudie. Diagnostica 2004, 50:171-181.
22. Kroenke K., Spitzer R.L., Williams J.B. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosomatic Medicine 2002, 64:258-266.
23. Löwe B., Unutzer J., Callahan C.M., Perkins A.J., Kroenke K. Monitoring depression treatment outcomes with the patient health questionnaire-9. Medical Care 2004, 42:1194-1201.
24. Löwe B., Kroenke K., Herzog W., Gräfe K. Measuring depression outcome with a brief self-report instrument: sensitivity to change of the Patient Health Questionnaire (PHQ-9). Journal of Affective Disorders 2004, 81:61-66.
25. Löwe B., Spitzer R.L., Gräfe K., Kroenke K., Quenter A., Zipfel S., et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. Journal of Affective Disorders 2004, 78:131-140.
26. Spitzer R.L., Kroenke K., Williams J.B., Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Archives of Internal Medicine 2006, 166:1092-1097.
27. Löwe B., Decker O., Müller S., Brähler E., Schellberg D., Herzog W., et al. Validation and standardization of the Generalized Anxiety Disorder screener (GAD-7) in the general population. Medical Care 2008, 46:266-274.
28. Pilowsky I. Dimensions of hypochondriasis. British Journal of Psychiatry 1967, 113:89-93.
29. Rief W., Ihle D., Pilger F. A new approach to assess illness behaviour. Journal of Psychosomatic Research 2003, 54:405-414.
30. Hiller W., Rief W., Elefant S., Margraf J., Kroymann R., Leibbrand R., et al. Dysfunktionale Kognitionen bei Patienten mit Somatisierungssyndrom. Zeitschrift für Klinische Psychologie 1997, 26:226-234.
31. Bullinger M., Kirchberger I. SF-36. Fragebogen zum Gesundheitszustand. Handanweisung 1998, Hogrefe, Göttingen.
32. Hiller W., Rief W., Fichter M.M. Dimensional and categorical approaches to hypochondriasis. Psychological Medicine 2002, 32:707-718.
33. Nagel A., Voigt K., Langs G., Wollburg E., Weinmann N., Schmid M., et al. Assessment of psychological symptoms in patients with somatoform disorders: the Somatic Symptoms Experiences Questionnaire (SSEQ) [Erfassung psychischer Symptome bei Patienten mit Somatoformen Störungen: Der Somatic Symptoms Experiences Questionnaire (SSEQ)]. Psychologische Medizin 2012, 92-93. (Special Edition DKPM 2012).
34. Sattel H., Lahmann C., Gundel H., Guthrie E., Kruse J., Noll-Hussong M., et al. Brief psychodynamic interpersonal psychotherapy for patients with multisomatoform disorder: randomised controlled trial. The British Journal of Psychiatry 2012, 200:60-67.
35. Rief W., Isaac M. Are somatoform disorders 'mental disorders'? A contribution to the current debate. Current Opinion in Psychiatry 2007, 20:143-146.
36. Gureje O., Simon G.E. The natural history of somatization in primary care. Psychological Medicine 1999, 29:669-676.
37. Rief W., Rojas G. Stability of somatoform symptoms-implications for classification. Psychosomatic Medicine 2007, 69:864-869.